Otamixaban

CAS No. 193153-04-7

Otamixaban( FXV-673 )

Catalog No. M13026 CAS No. 193153-04-7

A potent and selective factor Xa (FXa) inhibitor with Ki of 0.4 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 202 Get Quote
50MG 896 Get Quote
100MG 1341 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Otamixaban
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent and selective factor Xa (FXa) inhibitor with Ki of 0.4 nM.
  • Description
    A potent and selective factor Xa (FXa) inhibitor with Ki of 0.4 nM; shows >1,000-fold selectivity over thrombin, activated protein C (aPC), plasmin, and tissue-plasminogen activator (t-PA); dose-dependently prolongs the time to vessel occlusion and inhibits thrombus formation in canine models of thrombosis.Thrombosis Phase 3 Discontinued.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    FXV-673
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Factor Xa
  • Recptor
    Factor Xa
  • Research Area
    Cardiovascular Disease
  • Indication
    Thrombosis

Chemical Information

  • CAS Number
    193153-04-7
  • Formula Weight
    446.4984
  • Molecular Formula
    C25H26N4O4
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    C[C@@H](NC(C1=CC=C(C2=CC=[N+]([O-])C=C2)C=C1)=O)[C@@H](CC3=CC=CC(C(N)=N)=C3)C(OC)=O
  • Chemical Name
    Benzenepropanoic acid, 3-(aminoiminomethyl)-.alpha.-[(1R)-1-[[4-(1-oxido-4-pyridinyl)benzoyl]amino]ethyl]-, methyl ester, (.alpha.R)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Guertin KR, et al. Bioorg Med Chem Lett. 2002 Jun 17;12(12):1671-4. 2. Chu V, et al. Thromb Res. 2001 Aug 15;103(4):309-24. 3. Rebello SS, et al. J Cardiovasc Pharmacol. 2001 Aug;38(2):288-97.
molnova catalog
related products
  • Asundexian

    Asundexian (BAY-2433334) is a potent and orally active inhibitor of the coagulation factor FXIa that directly and reversibly binds to the active site of FXIa, thereby inhibiting its activity.Asundexian has an IC50 of 1 nM for human FXIa in buffer.

  • LY-517717

    A potent, selective, and orally bioavailable factor Xa (FXa) inhibitor for prevention and treatment of thromboembolic diseases.

  • VER-49009

    VER-49009 is an effective HSP90 inhibitor(IC50 =25 nM, Kd=78 nM).